Industry Developments

BMI anticipates healthy growth in the over-the-counter (OTC) pharmaceutical market in France over the next five years. Driven by a mixture of increased liberalisation and de-reimbursement... 2008-07-03

A recently published Royal Decree has set out new regulations for Spain's pharmaceutical supply chain. The decree, which replaces the two published in 1997, denotes the maximum margins... 2008-07-02

A recently published Royal Decree has set out new regulations for Spain's pharmaceutical supply chain. The decree, which replaces the two published in 1997, denotes the maximum margins... 2008-07-02

The French government's plans to reduce reimbursement levels for pharmaceuticals used by the chronically ill have been widely condemned by members of parliament (MPs). Parti Socialiste... 2008-06-27

A new report from the London School of Economics assessing the pharmaceutical policies in Finland has identified a number of challenges and possible methods for overcoming rising... 2008-06-27

In keeping with Roche's commitment to developing cancer therapies, the company has acquired worldwide exclusive rights to an early stage cancer therapy that is being co-developed... 2008-06-24

The Swiss biotech sector attracted record levels of investment and healthy market growth during 2007, according Swiss Biotech's 2008 annual report. However, while company revenues... 2008-06-20

New GlaxoSmithKline CEO Andrew Witty has put forward plans for the company's strategy, with a combination of more focused research strategies and a diversification of interests. Witty,... 2008-06-17

In a development that could significantly cut the cost of producing biopharmaceuticals, Dutch firms DSM Biologics and Crucell have announced record yield results using Crucell's human... 2008-06-17

As a result of the growing popularity of investing in ethical companies, along with the ongoing goal of providing developing countries with better access to medicines, the Netherlands-based... 2008-06-16